History: My husband learned he had CLL in March 2022 (he is muted TP53 and 17p depleted) - he was accepted in a Dana-Farber study for his particular CLL with treatments of A&O&V. (Acalabrutinib, obinutuzumab and venetoclax).He finished obinutuzumab.
Currently: after 11 months, February 2023, of immunotherapy, my hubby's blood revealed negative MRD. In April he will have a BMB to see if this too is negative. If there is a small amount of CLL in his bone marrow he will continue to take A&V for an other 9 months. I'm praying he is in remission.